123 related articles for article (PubMed ID: 28478022)
41. Development of a novel rabbit model of abdominal aortic aneurysm via a combination of periaortic calcium chloride and elastase incubation.
Bi Y; Zhong H; Xu K; Zhang Z; Qi X; Xia Y; Ren L
PLoS One; 2013; 8(7):e68476. PubMed ID: 23844207
[TBL] [Abstract][Full Text] [Related]
42. A Novel Modification of the Murine Elastase Infusion Model of Abdominal Aortic Aneurysm Formation.
Hu G; Dong Z; Fu W
Ann Vasc Surg; 2017 Jul; 42():246-253. PubMed ID: 28288888
[TBL] [Abstract][Full Text] [Related]
43. EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4.
Kamata R; Bumdelger B; Kokubo H; Fujii M; Yoshimura K; Ishida T; Ishida M; Yoshizumi M
PLoS One; 2016; 11(10):e0165132. PubMed ID: 27764222
[TBL] [Abstract][Full Text] [Related]
44. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms.
Mata KM; Tefé-Silva C; Floriano EM; Fernandes CR; Rizzi E; Gerlach RF; Mazzuca MQ; Ramos SG
Cardiovasc Pathol; 2015; 24(2):110-20. PubMed ID: 25466491
[TBL] [Abstract][Full Text] [Related]
45. Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice.
Inoue N; Muramatsu M; Jin D; Takai S; Hayashi T; Katayama H; Kitaura Y; Tamai H; Miyazaki M
Atherosclerosis; 2009 Jun; 204(2):359-64. PubMed ID: 18996524
[TBL] [Abstract][Full Text] [Related]
46. In vivo optical molecular imaging of matrix metalloproteinase activity in abdominal aortic aneurysms correlates with treatment effects on growth rate.
Sheth RA; Maricevich M; Mahmood U
Atherosclerosis; 2010 Sep; 212(1):181-7. PubMed ID: 20542274
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of AAA in a rat model by treatment with ACEI perindopril.
Xiong F; Zhao J; Zeng G; Huang B; Yuan D; Yang Y
J Surg Res; 2014 Jun; 189(1):166-73. PubMed ID: 24602481
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of inducible nitric oxide synthase limits nitric oxide production and experimental aneurysm expansion.
Johanning JM; Franklin DP; Han DC; Carey DJ; Elmore JR
J Vasc Surg; 2001 Mar; 33(3):579-86. PubMed ID: 11241130
[TBL] [Abstract][Full Text] [Related]
49. [Suppression of abdominal aortic aneurysm by hydrogen through chemokine-like factor1].
Chen F; Zhang T; Xiong J; Guo W; Pan X; Shen C; Song Y; Jia S; Liu J
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):59-61. PubMed ID: 24721310
[TBL] [Abstract][Full Text] [Related]
50. Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.
Zhang XJ; He C; Tian K; Li P; Su H; Wan JB
Vascul Pharmacol; 2015 Oct; 73():86-95. PubMed ID: 25912763
[TBL] [Abstract][Full Text] [Related]
51. [A study on residual strain of abdominal aortic aneurysm after intraperitoneal administration of saturated hydrogen saline in rats].
Song Y; Chen F; Xiong J; Guo W; Pan X; Jia S; Liu J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):881-4. PubMed ID: 24063183
[TBL] [Abstract][Full Text] [Related]
52. CCR2 Positron Emission Tomography for the Assessment of Abdominal Aortic Aneurysm Inflammation and Rupture Prediction.
English SJ; Sastriques SE; Detering L; Sultan D; Luehmann H; Arif B; Heo GS; Zhang X; Laforest R; Zheng J; Lin CY; Gropler RJ; Liu Y
Circ Cardiovasc Imaging; 2020 Mar; 13(3):e009889. PubMed ID: 32164451
[TBL] [Abstract][Full Text] [Related]
53. Fucoidan interferes with Porphyromonas gingivalis-induced aneurysm enlargement by decreasing neutrophil activation.
Alsac JM; Delbosc S; Rouer M; Journé C; Louedec L; Meilhac O; Michel JB
J Vasc Surg; 2013 Mar; 57(3):796-805. PubMed ID: 23141684
[TBL] [Abstract][Full Text] [Related]
54. Suppression of experimental abdominal aortic aneurysm in a rat model by the phosphodiesterase 3 inhibitor cilostazol.
Zhang Q; Huang JH; Xia RP; Duan XH; Jiang YB; Jiang Q; Sun WJ
J Surg Res; 2011 May; 167(2):e385-93. PubMed ID: 21392796
[TBL] [Abstract][Full Text] [Related]
55. High-mobility group box 1 protein blockade suppresses development of abdominal aortic aneurysm.
Kohno T; Anzai T; Kaneko H; Sugano Y; Shimizu H; Shimoda M; Miyasho T; Okamoto M; Yokota H; Yamada S; Yoshikawa T; Okada Y; Yozu R; Ogawa S; Fukuda K
J Cardiol; 2012 May; 59(3):299-306. PubMed ID: 22365948
[TBL] [Abstract][Full Text] [Related]
56. Quercetin reduces oxidative stress and inhibits activation of c‑Jun N‑terminal kinase/activator protein‑1 signaling in an experimental mouse model of abdominal aortic aneurysm.
Wang L; Cheng X; Li H; Qiu F; Yang N; Wang B; Lu H; Wu H; Shen Y; Wang Y; Jing H
Mol Med Rep; 2014 Feb; 9(2):435-42. PubMed ID: 24337353
[TBL] [Abstract][Full Text] [Related]
57. Pharmacologic blockade and genetic deletion of androgen receptor attenuates aortic aneurysm formation.
Davis JP; Salmon M; Pope NH; Lu G; Su G; Meher A; Ailawadi G; Upchurch GR
J Vasc Surg; 2016 Jun; 63(6):1602-1612.e2. PubMed ID: 26817611
[TBL] [Abstract][Full Text] [Related]
58. Suppression of experimental abdominal aortic aneurysms in the mice by treatment with Ginkgo biloba extract (EGb 761).
Wang L; Bai Y; Wang B; Cui H; Wu H; Lv JR; Mei Y; Zhang JS; Liu S; Qi LW; Chen Y
J Ethnopharmacol; 2013 Oct; 150(1):308-15. PubMed ID: 24012526
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of development of abdominal aortic aneurysm by glycolysis restriction.
Tsuruda T; Hatakeyama K; Nagamachi S; Sekita Y; Sakamoto S; Endo GJ; Nishimura M; Matsuyama M; Yoshimura K; Sato Y; Onitsuka T; Imamura T; Asada Y; Kitamura K
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1410-7. PubMed ID: 22499992
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of experimental abdominal aortic aneurysm in a rat model by way of tanshinone IIA.
Shang T; Liu Z; Zhou M; Zarins CK; Xu C; Liu CJ
J Surg Res; 2012 Dec; 178(2):1029-37. PubMed ID: 22640888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
